MENU
+Compare
BOUT
ETF ticker: NYSE ARCA
AS OF
Jul 17 closing price
Price
$37.33
Change
+$0.51 (+1.39%)
Net Assets
11.24M

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
BOUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BOUT with price predictions
Jul 18, 2025

BOUT's RSI Oscillator sits in overbought zone for 1 day

Watch for a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BOUT broke above its upper Bollinger Band on July 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on BOUT as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BOUT just turned positive on July 17, 2025. Looking at past instances where BOUT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in of 369 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 287 cases where BOUT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Alibaba Group Holding Limited (NYSE:BABA), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Southern Company (The) (NYSE:SO), Enterprise Products Partners LP (NYSE:EPD), Wheaton Precious Metals Corp (NYSE:WPM), Okta (NASDAQ:OKTA).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the Innovator IBD® Breakout Opps ETF ETF is 138.18B. The market cap for tickers in the group ranges from 1.35B to 281.58B. BABA holds the highest valuation in this group at 281.58B. The lowest valued company is EH at 1.35B.

High and low price notable news

The average weekly price growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was 3%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was -8%. KTOS experienced the highest price growth at 14%, while ASND experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Innovator IBD® Breakout Opps ETF ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was -8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 56
Price Growth Rating: 47
SMR Rating: 52
Profit Risk Rating: 41
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
BOUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Fundamentals
Details
Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com